Regenovva

NIH awards 4

Annual award amounts. Total $1.7M.

• Jul 29, 2026 NIH award 5R44DK141418-02 FY2026: $339,169 awarded for that fiscal year; activity R44 (SBIR); PI VITEK, MICHAEL PETER; recipient as written: REGENNOVA, INC., DURHAM, NC. Arginine-Polyamine Pathway Inhibitor for Treat source ↗
• Jul 17, 2025 NIH award 1R44DK141418-01A1 FY2025: $349,325 awarded for that fiscal year; activity R44 (SBIR); PI VITEK, MICHAEL PETER; recipient as written: REGENNOVA, INC., DURHAM, NC. Arginine-Polyamine Pathway Inhibitor for Tre source ↗
• Mar 16, 2023 NIH award 1R41AG078111-01A1 FY2023: $500,000 awarded for that fiscal year; activity R41 (STTR); PI VITEK, MICHAEL PETER; recipient as written: REGENNOVA, INC., DURHAM, NC. A Therapeutic Role for Apolipoprotein-E in t source ↗
• Sep 9, 2022 NIH award 1R41NS127666-01A1 FY2022: $499,900 awarded for that fiscal year; activity R41 (STTR); PI VITEK, MICHAEL PETER; recipient as written: REGENNOVA, INC., DURHAM, NC. Therapeutic Reduction of Cerebral Amyloid An source ↗